BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34578828)

  • 1. Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD.
    Di Mauro S; Salomone F; Scamporrino A; Filippello A; Morisco F; Guido M; Lembo V; Cossiga V; Pipitone RM; Grimaudo S; Malaguarnera R; Purrello F; Piro S
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
    Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
    J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis.
    Chen Y; Huang H; Xu C; Yu C; Li Y
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28275212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin-Induced Changes of the Coding Transcriptome and Non-Coding RNAs in the Livers of Non-Alcoholic Fatty Liver Disease Mice.
    Guo J; Zhou Y; Cheng Y; Fang W; Hu G; Wei J; Lin Y; Man Y; Guo L; Sun M; Cui Q; Li J
    Cell Physiol Biochem; 2018; 45(4):1487-1505. PubMed ID: 29466788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
    He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
    Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coffee enhances the expression of chaperones and antioxidant proteins in rats with nonalcoholic fatty liver disease.
    Salomone F; Li Volti G; Vitaglione P; Morisco F; Fogliano V; Zappalà A; Palmigiano A; Garozzo D; Caporaso N; D'Argenio G; Galvano F
    Transl Res; 2014 Jun; 163(6):593-602. PubMed ID: 24365744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease.
    Lee KC; Hsieh YC; Chan CC; Sun HJ; Huang YH; Hou MC; Lin HC
    Lab Invest; 2019 Jul; 99(8):1203-1216. PubMed ID: 30918325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive effects of caffeine on nicotine plus high-fat diet-induced hepatic steatosis and gain weight: a possible explanation for why obese smokers with high coffee consumption tend to be leaner.
    Lu N; Mei X; Li X; Tang X; Yang G; Xiang W
    Br J Nutr; 2024 Apr; 131(8):1342-1351. PubMed ID: 38149470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA FLRL2 alleviated nonalcoholic fatty liver disease through Arntl-Sirt1 pathway.
    Chen Y; Chen X; Gao J; Xu C; Xu P; Li Y; Zhu Y; Yu C
    FASEB J; 2019 Oct; 33(10):11411-11419. PubMed ID: 31311301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients.
    Pan X; Wang P; Luo J; Wang Z; Song Y; Ye J; Hou X
    Endocrine; 2015 Apr; 48(3):834-47. PubMed ID: 25138963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
    Liu J; Tang T; Wang GD; Liu B
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
    [No Abstract]   [Full Text] [Related]  

  • 13. Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD.
    Gehrke N; Biedenbach J; Huber Y; Straub BK; Galle PR; Simon P; Schattenberg JM
    Sci Rep; 2019 Mar; 9(1):4007. PubMed ID: 30850619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes.
    Wang H; Cao Y; Shu L; Zhu Y; Peng Q; Ran L; Wu J; Luo Y; Zuo G; Luo J; Zhou L; Shi Q; Weng Y; Huang A; He TC; Fan J
    J Cell Mol Med; 2020 Jan; 24(2):1399-1412. PubMed ID: 31809000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
    Li X; Wang Z; Klaunig JE
    Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP Citrate Lyase and LncRNA NONMMUT010685 Play Crucial Role in Nonalcoholic Fatty Liver Disease Based on Analysis of Microarray Data.
    Ma TT; Huang C; Ni Y; Yang Y; Li J
    Cell Physiol Biochem; 2018; 51(2):871-885. PubMed ID: 30466110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic transcriptome analysis from HFD-fed mice defines a long noncoding RNA regulating cellular cholesterol levels.
    Chen Q; Xiong C; Jia K; Jin J; Li Z; Huang Y; Liu Y; Wang L; Luo H; Li H; Meng QH; Li W
    J Lipid Res; 2019 Feb; 60(2):341-352. PubMed ID: 30504232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coffee modulates insulin-hepatocyte nuclear factor-4α-Cyp7b1 pathway and reduces oxysterol-driven liver toxicity in a nonalcoholic fatty liver disease mouse model.
    Kakiyama G; Minowa K; Rodriguez-Agudo D; Martin R; Takei H; Mitamura K; Ikegawa S; Suzuki M; Nittono H; Fuchs M; Heuman DM; Zhou H; Pandak WM
    Am J Physiol Gastrointest Liver Physiol; 2022 Nov; 323(5):G488-G500. PubMed ID: 36193897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maraviroc, a CCR5 antagonist, ameliorates the development of hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD).
    Pérez-Martínez L; Pérez-Matute P; Aguilera-Lizarraga J; Rubio-Mediavilla S; Narro J; Recio E; Ochoa-Callejero L; Oteo JA; Blanco JR
    J Antimicrob Chemother; 2014 Jul; 69(7):1903-10. PubMed ID: 24651825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide analysis of long noncoding RNA expression profiles in patients with non-alcoholic fatty liver disease.
    Sun C; Liu X; Yi Z; Xiao X; Yang M; Hu G; Liu H; Liao L; Huang F
    IUBMB Life; 2015 Nov; 67(11):847-52. PubMed ID: 26472541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.